Booz Allen Hamilton (BAH) Competitors $107.29 -5.76 (-5.10%) Closing price 07/28/2025 03:59 PM EasternExtended Trading$107.36 +0.07 (+0.07%) As of 07/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BAH vs. CCRN, CACI, LDOS, SAIC, CTSH, IT, DOX, EPAM, TDC, and HCKTShould you be buying Booz Allen Hamilton stock or one of its competitors? The main competitors of Booz Allen Hamilton include Cross Country Healthcare (CCRN), CACI International (CACI), Leidos (LDOS), Science Applications International (SAIC), Cognizant Technology Solutions (CTSH), Gartner (IT), Amdocs (DOX), EPAM Systems (EPAM), Teradata (TDC), and The Hackett Group (HCKT). Booz Allen Hamilton vs. Its Competitors Cross Country Healthcare CACI International Leidos Science Applications International Cognizant Technology Solutions Gartner Amdocs EPAM Systems Teradata The Hackett Group Cross Country Healthcare (NASDAQ:CCRN) and Booz Allen Hamilton (NYSE:BAH) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk. Is CCRN or BAH more profitable? Booz Allen Hamilton has a net margin of 8.70% compared to Cross Country Healthcare's net margin of -1.41%. Booz Allen Hamilton's return on equity of 71.88% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Cross Country Healthcare-1.41% 2.56% 1.84% Booz Allen Hamilton 8.70%71.88%11.68% Which has more volatility and risk, CCRN or BAH? Cross Country Healthcare has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, Booz Allen Hamilton has a beta of 0.48, meaning that its stock price is 52% less volatile than the S&P 500. Do analysts rate CCRN or BAH? Cross Country Healthcare currently has a consensus price target of $17.93, suggesting a potential upside of 29.83%. Booz Allen Hamilton has a consensus price target of $134.00, suggesting a potential upside of 24.90%. Given Cross Country Healthcare's higher probable upside, analysts clearly believe Cross Country Healthcare is more favorable than Booz Allen Hamilton.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Booz Allen Hamilton 2 Sell rating(s) 6 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.25 Does the media prefer CCRN or BAH? In the previous week, Booz Allen Hamilton had 40 more articles in the media than Cross Country Healthcare. MarketBeat recorded 44 mentions for Booz Allen Hamilton and 4 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.87 beat Booz Allen Hamilton's score of 0.78 indicating that Cross Country Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Booz Allen Hamilton 18 Very Positive mention(s) 4 Positive mention(s) 14 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of CCRN or BAH? 96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 91.8% of Booz Allen Hamilton shares are held by institutional investors. 4.9% of Cross Country Healthcare shares are held by company insiders. Comparatively, 0.9% of Booz Allen Hamilton shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has stronger valuation & earnings, CCRN or BAH? Booz Allen Hamilton has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Booz Allen Hamilton, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCross Country Healthcare$1.34B0.34-$14.56M-$0.53-26.06Booz Allen Hamilton$11.98B1.11$935M$8.1413.18 SummaryBooz Allen Hamilton beats Cross Country Healthcare on 13 of the 17 factors compared between the two stocks. Get Booz Allen Hamilton News Delivered to You Automatically Sign up to receive the latest news and ratings for BAH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BAH vs. The Competition Export to ExcelMetricBooz Allen HamiltonConsulting IndustryBusiness SectorNYSE ExchangeMarket Cap$14.04B$7.42B$14.97B$21.14BDividend Yield1.95%1.74%2.73%3.59%P/E Ratio13.1824.3629.1228.31Price / Sales1.112.8349.6755.92Price / Cash14.6117.4526.7218.21Price / Book13.555.866.574.70Net Income$935M$272.15M$197.16M$992.76M7 Day Performance-4.07%-2.09%-0.09%0.62%1 Month Performance4.01%0.52%5.25%4.54%1 Year Performance-25.68%-9.38%25.70%10.20% Booz Allen Hamilton Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BAHBooz Allen Hamilton4.884 of 5 stars$107.29-5.1%$134.00+24.9%-23.3%$14.04B$11.98B13.1835,800Earnings ReportDividend AnnouncementAnalyst ForecastHigh Trading VolumeCCRNCross Country Healthcare3.628 of 5 stars$13.36+4.5%$17.93+34.2%-16.4%$437.94M$1.34B-25.218,205Upcoming EarningsCACICACI International3.3894 of 5 stars$478.60-0.9%$520.31+8.7%+3.1%$10.52B$7.66B22.5924,000LDOSLeidos4.4314 of 5 stars$160.76-1.1%$175.15+9.0%+7.1%$20.69B$16.93B16.1748,000Positive NewsSAICScience Applications International3.8827 of 5 stars$112.54-0.8%$124.73+10.8%-7.3%$5.28B$7.51B18.9826,000Positive NewsCTSHCognizant Technology Solutions4.9009 of 5 stars$75.42-0.3%$86.18+14.3%+1.1%$37.18B$19.74B15.88336,800Positive NewsUpcoming EarningsAnalyst ForecastITGartner4.6989 of 5 stars$352.95-0.7%$507.56+43.8%-25.1%$27.17B$6.30B21.9621,044DOXAmdocs4.7757 of 5 stars$88.03-1.6%$105.33+19.7%-0.1%$9.94B$5.00B18.5329,058Positive NewsEPAMEPAM Systems4.9463 of 5 stars$165.60+0.5%$231.73+39.9%-19.7%$9.38B$4.73B23.1661,200Positive NewsTDCTeradata2.751 of 5 stars$21.53-0.3%$27.25+26.6%-30.0%$2.06B$1.75B15.165,700Positive NewsHCKTThe Hackett Group4.0306 of 5 stars$23.23-0.4%$31.33+34.9%-10.8%$642.54M$313.86M27.331,478 Related Companies and Tools Related Companies Cross Country Healthcare Competitors CACI International Competitors Leidos Competitors Science Applications International Competitors Cognizant Technology Solutions Competitors Gartner Competitors Amdocs Competitors EPAM Systems Competitors Teradata Competitors The Hackett Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BAH) was last updated on 7/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Booz Allen Hamilton Holding Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Booz Allen Hamilton With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
